Dr. Robert C. Doekel JR., M.D.
Sleep Medicine (Sleep Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- University of Louisville School of Medicine (1967)
- Years since graduation
- 59
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 142
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1967Medical school: University of Louisville School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Sleep Medicine (Internal Medicine) Physician primary
AL license 00005953 -
Pulmonary Disease Physician
AL license 00005953
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Comprehensive Sleep Center PC (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 142
- Services billed
- 251
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 144 | 134 |
| Established patient office or other outpatient visit, 20-29 minutes | 96 | 69 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 41 | 40 |
| Sleep study in sleep lab (6 years or older) | 38 | 31 |
| New patient office or other outpatient visit, 45-59 minutes | 31 | 31 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dextroamphetamine-Amphetamine (dextroamphetamine/amphetamine) Other prescribers in Birmingham, AL | 192 |
| Modafinil Other prescribers in Birmingham, AL | 142 |
| Zolpidem Tartrate Other prescribers in Birmingham, AL | 123 |
| Gabapentin Other prescribers in Birmingham, AL | 117 |
| Clonazepam Other prescribers in Birmingham, AL | 108 |
| Dextroamphetamine-Amphet Er (dextroamphetamine/amphetamine) Other prescribers in Birmingham, AL | 81 |
| Armodafinil | 76 |
| Methylphenidate Hcl Other prescribers in Birmingham, AL | 61 |
| Sunosi (solriamfetol hcl) | 59 |
| Xywav (sodium,calcium,mag,pot oxybate) | 54 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 41 payments worth $1,081 in total to this clinician.
| Harmony Biosciences LLC | $333 |
|---|---|
| Axsome Therapeutics, Inc. | $278 |
| Avadel Cns Pharmaceuticals, LLC | $247 |
| Jazz Pharmaceuticals Inc. | $177 |
| Tris Pharma Inc | $45.37 |
| Food and Beverage | $1,011 |
|---|---|
| Education | $69.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Harmony Biosciences LLC Aug 28, 2025 | Education in-kind | $69.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $30,812 in research payments for these studies, mostly to the institutions running them.
- A Prospective, Open-Label, Single-Arm, Multicenter Study to Evaluate the Effect of Low-Sodium Oxybate Oral Solution (XYWAV) on Sleepiness, Polysomnography, and Functional Outcomes in Adult Participants Aged 18 to 75 Y…
Jazz Pharmaceuticals Inc. - A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2
Alkermes, Inc. · Completed · NCT06555783 - Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
Avadel Cns Pharmaceuticals, LLC · Completed · NCT06525077
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.